Improved response of B-cell malignancies to rituximab upon FOXO1 inhibition.
Authors: Pyrzynska B., Zerrouqi A., Dwojak M., Morlino G., Zapala P., Miazek N., Zagozdzon A., Calado D., Golab J., Winiarska M.
Published in: EACR-AACR-SIC Special Conference 2017: The Challenges of Optimizing Immuno- and Targeted Therapies.
Publication type: conference